Submit Deal

Submit Deal

Cover Image John Mulligan

John Mulligan

Founder and CEO at GOOD THERAPEUTICS

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 216 M

Avg. Deal Size£ 216 M

Market Context

Sort

07 Sep 2022|United States|Pharmaceuticals

Target: GOOD THERAPEUTICS

Bidder: ROCHE HOLDINGS AG

4 Service Providers

3 Target | 1 Bidder

21 Dealmakers

20 Target | 1 Bidder

£ 216 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite